Precision Warheads: How Antibody–Drug Conjugates Are Redefining Lung Cancer Treatment
A comprehensive review details how antibody–drug conjugates targeting TROP2, HER2, c-MET, and other antigens are transforming non-small cell lung cancer ...
A comprehensive review details how antibody–drug conjugates targeting TROP2, HER2, c-MET, and other antigens are transforming non-small cell lung cancer ...
New research links the SERPINE1–CA9 gene axis to both aggressive growth and cisplatin resistance in head and neck squamous cell ...
A new review outlines how multi-omics, CRISPR functional genomics, artificial intelligence and host-directed immunotherapy can be integrated into a precision ...
A new physics-in neural network framework called GRNvelo unifies gene regulatory network dynamics with cell population behavior, accurately reconstructing cell ...
New research reveals that the chromatin-modifying enzyme SMYD3 orchestrates DNA double-strand break repair in gastric cancer, and that blocking it ...
A newly reported case shows that first-line lorlatinib achieved durable systemic and intracranial disease control in a patient with the ...
A new review highlights how Plasmodium rhomboid proteases, essential intramembrane enzymes governing parasite invasion and survival, are emerging as validated ...
Researchers identified an ASCL1–WNT11–ERK feed-forward loop that sustains pyrotinib resistance in HER2-positive breast cancer and designed a HER2-targeted nanoparticle that ...
A new review in Cancer Reports details how the senescence-associated secretory phenotype can both suppress and fuel tumors, and how ...
A province-wide study in Jiangxi, China, found that exposure to antiretroviral therapy nearly tripled the prevalence of multidrug resistance among ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine